Daily as of 3 Nov 16:00 ET
- Price
- above both $4.55 vs 50 $3.58 / 200 $3.50
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- 🟨Golden cross 29 Oct 2026 · projected 13 bars out
PRME | Prime MedicineNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$4.55
+$0.11 (+2.48%)
Prime Medicine (PRME) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $4.72 vs 50 $3.52 / 200 $6.27
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- above both $4.56 vs 50 $3.79 / 200 $3.43
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 20 Oct 2026 · projected 8 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 29 Oct 2026 | 🟨Golden moderate | daily | 13 bars out | Active Cross Test |
| 20 Oct 2026 | 🟨Golden | 4-hour | 8 bars out | Not tested |
| 8 Oct 2026 | 💀Death | 4-hour | 1 bar out | 1 bar cross test |
| 7 Oct 2026 | 🟨Golden | 4-hour | 15 bars out | Not tested |
| 6 Oct 2026 | 💀Death | 4-hour | 27 bars out | 1 bar cross test |
About PRME
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$10.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall